Question 1

Does JPMorgan Chase own FDMT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 402,137 shares of FDMT (4D Molecular Therapeutics in), worth $5.2M.

Question 2

How many shares of FDMT does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 402,137 shares of FDMT (4D Molecular Therapeutics in).

Question 3

What is JPMorgan Chase's FDMT position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's FDMT position is worth $5.2M.

Question 4

Is JPMorgan Chase buying or selling FDMT?

Accepted Answer

In Q2 2026, JPMorgan Chase reduced its FDMT position by 13,518 shares (-3.3%).

Question 5

When did JPMorgan Chase first buy FDMT?

Accepted Answer

JPMorgan Chase already held FDMT in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	402,137	-3.3%	$5.2M	0.0%	$13.30	0
2026-Q1	Increased	415,655	+48.7%	$3.6M	0.0%	$8.46	37
2025-Q4	Decreased	279,505	-45.6%	$2.1M	0.0%	$7.58	0
2025-Q3	Decreased	513,515	-42.2%	$4.5M	0.0%	$8.35	0
2025-Q2	Increased	888,016	+0.1%	$3.3M	0.0%	$3.84	26
2025-Q1	Increased	886,705	+8.1%	$2.9M	0.0%	$3.63	28
2024-Q4	Increased	820,069	+159.5%	$4.6M	0.0%	$5.57	43
2024-Q3	First report	315,983	-	$3.4M	0.0%	$10.81	0

FDMT8 quarters

FDMT
8 quarters